Related Experiment Video
Updated: Apr 22, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Adaptive Mobile Health Intervention to Reduce Excess Gestational Weight Gain: A Cluster-Randomized Clinical Trial
Monique M Hedderson1,2,3, Susan D Brown2,3,4, Charles P Quesenberry1,2
1Kaiser Permanente Northern California, Division of Research, Pleasanton.
JAMA Network Open
|April 20, 2026
Summary
An adaptive mobile health intervention significantly reduced excessive gestational weight gain (GWG) in pregnant patients with overweight or obesity. This technology-driven approach offers a scalable solution for managing GWG and improving perinatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Digital Health Interventions
Background:
- Excessive gestational weight gain (GWG) affects 50% of pregnant individuals with overweight or obesity.
- High GWG is linked to adverse perinatal complications.
- There is a need for scalable, evidence-based lifestyle interventions to manage GWG.
Purpose of the Study:
- To evaluate an adaptive mobile health (mHealth) lifestyle intervention combined with standard care.
- To determine if this intervention reduces excessive GWG compared to standard care alone.
Main Methods:
- A cluster-randomized clinical trial involving pregnant patients with a prepregnancy BMI between 25.0 and 39.9.
- Intervention group received mHealth support including personalized feedback, activity tracking, educational content, and lifestyle coaching.
- Standard care group received only routine care.
- Co-primary outcomes included the weekly rate and total GWG, assessed against Institute of Medicine (IOM) guidelines.
Main Results:
- The intervention group showed a significantly lower weekly rate of GWG (0.25 kg/week vs. 0.28 kg/week).
- Fewer patients in the intervention group exceeded IOM guidelines for weekly and total GWG (51.9% vs. 60.2% and 44.1% vs. 51.2%, respectively).
- Total GWG was also significantly lower in the intervention group (9.7 kg vs. 10.6 kg).
Conclusions:
- An adaptive mHealth lifestyle intervention effectively reduced both the rate and total amount of GWG in pregnant individuals with overweight or obesity.
- This technology-leveraging approach demonstrates potential for scalable management of GWG.
- Findings support the integration of digital health tools in prenatal care to mitigate risks associated with excessive GWG.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Drug Dosing: Obese Patients
353
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
353
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K

